- INHIBITORS OF PROTEIN KINASES
-
The present invention provides new compounds. The compounds are useful as CDK5 inhibitors, and accordingly they can be included in pharmaceuticals compositions for treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases. formula (I).
- -
-
Page/Page column 22; 24
(2010/08/07)
-
- Inhibitors of protein kinases
-
The present invention provides new compounds. The compounds are useful as CDK5 inhibitors, and accordingly they can be included in pharmaceutical compositions for treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases.
- -
-
Page/Page column 22; 24
(2008/12/08)
-
- INHIBITORS OF PROTEIN KINASES
-
The present invention provides new compounds. The compounds are useful as CDK5 inhibitors, and accordingly they can be included in pharmaceuticals compositions for treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases. formula (I).
- -
-
Page/Page column 49; 53
(2008/12/08)
-
- Piperazine, piperidine and tetrahydropyridine derivatives useful as 5-HT1 recepter agonists
-
A class of N-substituted piperazine, piperadine and tetrahyrdopyridine derivatives of formula (I), further substituted at the 4-position by an optionally substituted aryl-alkyl or heteroaryl-alkyl moiety, are selective agonists of 5-HT1 -like r
- -
-
-